Jeffrey Alan Tornheim

Professor Jeffrey Alan Tornheim is dedicated to fostering understanding of innovative diagnostic technologies to enhance treatment outcomes for drug-resistant tuberculosis. As an Assistant Professor of Medicine and Pediatrics at Johns Hopkins University, he is at the forefront of research in bacterial next-generation sequencing and multiomic host biomarkers. His work is pivotal in addressing the global challenge of drug-resistant tuberculosis, aiming to develop more effective pharmacologic assessments and interventions. Dr. Tornheim's academic journey began with an undergraduate degree from Brandeis University, followed by a medical degree from the Mount Sinai School of Medicine. His commitment to advancing medical knowledge led him to complete his residencies at Yale University, where he honed his clinical skills, and a fellowship at Johns Hopkins, where he further specialized in infectious diseases. In addition to his academic and research roles, Dr. Tornheim serves as a TB clinician at the Baltimore City Health Department. His clinical practice is deeply informed by his research, allowing him to apply cutting-edge findings directly to patient care. His involvement with several international organizations underscores his commitment to global health and collaboration in the fight against tuberculosis. Dr. Tornheim's contributions to the field have been recognized with numerous awards, including the prestigious W. Leigh Thompson Excellence in Research Award and the Fogarty International Clinical Scholar Award. These accolades reflect his dedication to excellence and innovation in medical research. Through his work, Dr. Tornheim continues to push the boundaries of what is possible in the diagnosis and treatment of drug-resistant tuberculosis. His efforts not only contribute to the scientific community but also have a tangible impact on the lives of patients worldwide.